The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

InhaleRx Limited (AU:IRX) has released an update. InhaleRx Limited has received ethics approval to commence Phase 2 clinical trials for ...

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday ...

InhaleRX Ltd (ASX:IRX) – a company which develops inhaled drug-device treatments for pain management and a range of mental ...

Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

Artelo Biosciences (ARTL) announced new data being presented today on ART26.12, Artelo’s lead clinical Fatty Acid Binding Protein 5, FABP5, inhibitor, in osteoarthritis, OA, pain at the 13th Annual ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

Avanos Medical announced today that a Centers for Medicare and Medicaid Services (CMS) payment rule benefits its infusion ...